Shockwave Medical Future Growth
Future criteria checks 3/6
Shockwave Medical is forecast to grow earnings and revenue by 18.6% and 16.2% per annum respectively. EPS is expected to grow by 16.5% per annum. Return on equity is forecast to be 18.8% in 3 years.
Key information
18.6%
Earnings growth rate
16.5%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 16.2% |
Future return on equity | 18.8% |
Analyst coverage | Good |
Last updated | 14 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,357 | 299 | 318 | 366 | 9 |
12/31/2025 | 1,136 | 242 | 239 | 260 | 13 |
12/31/2024 | 933 | 203 | 417 | 265 | 4 |
3/31/2024 | 788 | 163 | 166 | 198 | N/A |
12/31/2023 | 730 | 147 | 165 | 196 | N/A |
9/30/2023 | 671 | 244 | 143 | 177 | N/A |
6/30/2023 | 617 | 244 | 126 | 161 | N/A |
3/31/2023 | 557 | 241 | 121 | 150 | N/A |
12/31/2022 | 490 | 216 | 93 | 118 | N/A |
9/30/2022 | 430 | 88 | 69 | 86 | N/A |
6/30/2022 | 364 | 55 | 48 | 61 | N/A |
3/31/2022 | 299 | 29 | 23 | 34 | N/A |
12/31/2021 | 237 | -9 | 3 | 15 | N/A |
9/30/2021 | 176 | -38 | -29 | -18 | N/A |
6/30/2021 | 130 | -53 | -53 | -44 | N/A |
3/31/2021 | 84 | -71 | -75 | -64 | N/A |
12/31/2020 | 68 | -66 | -83 | -71 | N/A |
9/30/2020 | 59 | -65 | -83 | -71 | N/A |
6/30/2020 | 51 | -65 | -77 | -66 | N/A |
3/31/2020 | 51 | -57 | -66 | -58 | N/A |
12/31/2019 | 43 | -51 | -52 | -48 | N/A |
9/30/2019 | 34 | -48 | -48 | -45 | N/A |
6/30/2019 | 26 | -45 | -47 | -45 | N/A |
3/31/2019 | 18 | -44 | -47 | -45 | N/A |
12/31/2018 | 12 | -41 | -43 | -41 | N/A |
12/31/2017 | 2 | -31 | N/A | -30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 36M's forecast earnings growth (18.6% per year) is above the savings rate (0.7%).
Earnings vs Market: 36M's earnings (18.6% per year) are forecast to grow faster than the German market (17.3% per year).
High Growth Earnings: 36M's earnings are forecast to grow, but not significantly.
Revenue vs Market: 36M's revenue (16.2% per year) is forecast to grow faster than the German market (5.2% per year).
High Growth Revenue: 36M's revenue (16.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 36M's Return on Equity is forecast to be low in 3 years time (18.8%).